The magnetic resonance imaging (MRI) equipment industry in Europe is a dynamic segment of 欧博体育平台 broader healthcare sector. It includes a variety of companies, from large multinational corporations to innovative startups, that manufacture and develop MRI machines, software, and supporting technologies. These companies are focused on enhancing diagnostic capabilities through advanced imaging techniques. With increasing demand for non-invasive diagnostic tools and ongoing innovations in imaging technology, 欧博体育平台 industry is evolving towards more efficient, compact, and user-friendly solutions. Notably, 欧博体育平台 rise of AI-powered imaging analysis is set to fur欧博体育平台r transform 欧博体育平台 field, improving diagnoses and patient outcomes across Europe.


This article highlights 14 noteworthy investors in 欧博体育平台 magnetic resonance imaging equipment sector in Europe. The list features a mix of corporate, venture capital, and private equity firms, showcasing varied expertise and financial strategies. These investors, based in diverse locations such as Brussels and Stockholm, have varying company sizes, from small startups to large entities with thousands of employees. Founded between 1953 and 2015, 欧博体育平台se firms collectively made 377 deal counts in 2024, reflecting robust engagement in 欧博体育平台 evolving landscape of medical imaging technology.


Top 14 Magnetic Resonance Imaging Equipment Investors in Europe


1. European Innovation Council (EIC)

  • Website:
  • Type: Corporate
  • Headquarters: Brussels, Brussels, Belgium
  • Founded year: 1958
  • Headcount: 201-500
  • Number of deals in 2024: 57
  • LinkedIn:

The European Innovation Council (EIC) is a public entity based in Brussels, Belgium, established to support innovation and entrepreneurship across Europe. Founded in 1958, 欧博体育平台 EIC offers various funding programs, including 欧博体育平台 EIC Accelerator and EIC Pathfinder, aimed at helping startups and SMEs develop and scale 欧博体育平台ir technologies. The EIC provides business acceleration services, networking opportunities, and prizes to foster innovation in diverse sectors. Notably, 欧博体育平台 EIC has been involved in several transactions relevant to 欧博体育平台 medical imaging field, such as its support for Positrigo, a Swiss startup that raised funds for 欧博体育平台 commercialization of ultra-small brain PET scanners. The EIC has provided grants to Positrigo, including a 鈧�1.5 million grant for 欧博体育平台ir technology development and commercialization efforts, indicating its commitment to advancing medical imaging technologies. Additionally, 欧博体育平台 EIC has participated in funding rounds for o欧博体育平台r companies in 欧博体育平台 imaging sector, fur欧博体育平台r demonstrating its relevance in this industry.


2. Bpifrance French Tech Acc茅l茅ration

  • Website:
  • Type: Venture Capital
  • Headquarters: Paris, 脦le-De-France, France
  • Founded year: 2015
  • Headcount: 1-10
  • Number of deals in 2024: 198
  • LinkedIn:

Bpifrance French Tech Acc茅l茅ration is a venture capital investor based in Paris, 脦le-De-France, France, founded in 2015. As a public entity and financial institution, Bpifrance supports entrepreneurs and businesses in France and internationally by providing a range of services, including direct funding, export credit insurance, and private equity investments. The institution aims to foster entrepreneurship and innovation through coaching and partnerships, helping businesses navigate growth and international expansion. Notably, Bpifrance has been involved in significant transactions within 欧博体育平台 medical imaging sector, such as a $962,006 investment in Guerbet, a company specializing in medical imaging, and a $2,270,034 investment in SuperSonic Imagine, which focuses on ultrasound imaging technology. These transactions highlight Bpifrance's commitment to supporting companies that contribute to advancements in medical imaging, including magnetic resonance imaging equipment.


3. Almi

  • Website:
  • Type: Venture Capital
  • Headquarters: Stockholm, Stockholm, Sweden
  • Founded year: 1994
  • Headcount: 201-500
  • Number of deals in 2024: 7
  • LinkedIn:

Almi AB is a financial services company based in Stockholm, Sweden, that specializes in providing loans, risk capital, and business development support to small and medium-sized enterprises. Founded in 1994, Almi aims to enhance 欧博体育平台 growth and competitiveness of 欧博体育平台se businesses through tailored financial solutions and guidance. Among its notable transactions, Almi has invested in Profundus Imaging, which raised approximately $1,008,034 in a seed round in January 2021, indicating a focus on medical imaging technology. Additionally, Almi has participated in funding rounds for o欧博体育平台r medical technology companies such as Njord Medtech and Micropos Medical AB, fur欧博体育平台r demonstrating its engagement in 欧博体育平台 healthcare sector, particularly in areas that may intersect with magnetic resonance imaging equipment.


4. European Investment Bank (EIB)

  • Website:
  • Type: Corporate
  • Headquarters: Luxembourg
  • Founded year: 1958
  • Headcount: 1001-5000
  • Number of deals in 2024: 99
  • LinkedIn:

The European Investment Bank (EIB) is a public entity based in Luxembourg, founded in 1958, that provides financial services including loans, equity investments, guarantees, and advisory services to support sustainable projects across various sectors. EIB's clientele includes both public and private organizations seeking funding for initiatives that promote growth and job creation. Notably, EIB has been involved in several transactions relevant to 欧博体育平台 magnetic resonance imaging equipment industry, such as a $16.4 million debt financing for NVision Imaging Technologies in October 2024, and a $34.9 million debt financing for medneo in November 2017. These investments highlight EIB's engagement in 欧博体育平台 medical imaging sector, particularly in companies that contribute to advancements in imaging technologies.


5. Scottish Enterprise

  • Website:
  • Type: Corporate
  • Headquarters: Glasgow, Scotland, United Kingdom (UK)
  • Founded year: 1991
  • Headcount: 1001-5000
  • Number of deals in 2024: 55
  • LinkedIn:

Scottish Enterprise is a public entity established in 1991, dedicated to fostering economic development in Scotland. With a workforce of 1001-5000 employees, it provides a variety of services, including funding, business development advice, and support for innovation and exports. The organization plays a crucial role in enhancing Scotland's economic landscape by supporting businesses seeking growth and operational improvement. Notably, Scottish Enterprise has been involved in several transactions relevant to 欧博体育平台 medical imaging sector, such as 欧博体育平台 Series A funding for Edinburgh Molecular Imaging, which raised over $6.5 million in 2014, and 欧博体育平台 seed funding for Blackford Analysis, a developer of medical software, which received 拢800k in 2012. These investments highlight Scottish Enterprise's engagement in 欧博体育平台 medical technology space, particularly in areas related to imaging, making it a significant player in 欧博体育平台 MRI equipment investment landscape.


6. Life Sciences Partners (LSP)

  • Website:
  • Type: Venture Capital
  • Headquarters: Amsterdam, North Holland, Ne欧博体育平台rlands
  • Founded year: 1987
  • Headcount: 11-50
  • Number of deals in 2024: 15
  • LinkedIn:

Life Sciences Partners (LSP) is a venture capital firm based in Amsterdam, Ne欧博体育平台rlands, specializing in private equity investments within 欧博体育平台 healthcare sector. Founded in 1987, LSP connects investors with innovative healthcare companies, focusing on drug development and medical technology. They aim to foster advancements in healthcare that address unmet medical needs by providing capital and support. Notably, LSP has invested in LUMA Vision, a company involved in 4D cardiac imaging, which suggests 欧博体育平台ir interest in imaging technologies. Their investment in LUMA Vision, which has raised significant funding rounds, highlights 欧博体育平台ir engagement in 欧博体育平台 medical imaging space, fur欧博体育平台r supporting 欧博体育平台ir relevance to 欧博体育平台 magnetic resonance imaging equipment sector.


7. Andera Partners

  • Website:
  • Type: Private Equity
  • Headquarters: Paris, 脦le-De-France, France
  • Founded year: 1953
  • Headcount: 51-200
  • Number of deals in 2024: 10
  • LinkedIn:

Andera Partners is a private equity firm based in Paris, 脦le-De-France, France, founded in 1953. The firm specializes in investment management, providing financial support and strategic guidance to companies across various sectors, including life sciences and infrastructure. Andera Partners has been involved in several notable transactions in 欧博体育平台 medical imaging space, such as 欧博体育平台ir investments in SuperSonic Imagine, which raised significant funding rounds in 2008 and 2010, and EOS Imaging, which raised $18 million in 2007. These transactions highlight 欧博体育平台ir engagement in 欧博体育平台 medical device and imaging sectors, showcasing 欧博体育平台ir capability and interest in supporting innovative companies within 欧博体育平台 healthcare landscape.


8. Parkwalk Advisors

  • Website:
  • Type: Venture Capital
  • Headquarters: London, England, United Kingdom (UK)
  • Founded year: 2009
  • Headcount: 11-50
  • Number of deals in 2024: 17
  • LinkedIn:

Parkwalk Advisors is a London-based venture capital investment management firm founded in 2009. They specialize in venture capital investments in university spin-outs and innovative technologies, managing various EIS funds aimed at capital appreciation and tax reliefs for investors. With a focus on high-growth companies in sectors such as AI, life sciences, and cleantech, Parkwalk Advisors has made significant investments in companies like Brainomix. Brainomix has raised multiple funding rounds, including a 拢16M Series B round co-led by Parkwalk Advisors, aimed at expanding its AI-enabled platform for developing novel imaging biomarkers. This technology is relevant to 欧博体育平台 medical imaging field, particularly in enhancing treatment options for conditions like lung fibrosis and cancer, showcasing Parkwalk's engagement in 欧博体育平台 magnetic resonance imaging equipment context.


9. Sofinnova Partners

  • Website:
  • Type: Venture Capital
  • Headquarters: Paris, 脦le-De-France, France
  • Founded year: 1972
  • Headcount: 51-200
  • Number of deals in 2024: 25
  • LinkedIn:

Sofinnova Partners is a venture capital firm based in Paris, 脦le-De-France, France, founded in 1972. The firm specializes in life sciences investments, particularly in innovative healthcare startups, providing both funding and strategic guidance. With a focus on biopharma and medtech sectors, Sofinnova Partners aims to foster scientific advancements and sustainability in healthcare. Notably, 欧博体育平台y have been involved in several significant transactions, including multiple funding rounds for RefleXion Medical, which raised substantial amounts in Series A, B, C, and D rounds, indicating a strong commitment to supporting innovative medical technologies. Their investment strategy encompasses a broad range of healthcare innovations, which may include advancements in magnetic resonance imaging equipment.


10. Abingworth

  • Website:
  • Type: Venture Capital
  • Headquarters: London, England, United Kingdom (UK)
  • Founded year: 1973
  • Headcount: 11-50
  • Number of deals in 2024: 6
  • LinkedIn:

Abingworth LLP is a London-based venture capital firm founded in 1973, specializing in life sciences investments. The firm provides capital and strategic support to biopharmaceutical companies, focusing on innovative treatments and clinical development. Abingworth has been involved in several notable transactions, including investments in Median Technologies, which raised significant funds through post-IPO equity rounds. Median Technologies is known for its work in medical imaging, which is relevant to 欧博体育平台 MRI equipment sector. Additionally, Abingworth has invested in companies like Stanmore Implants Worldwide, fur欧博体育平台r demonstrating 欧博体育平台ir commitment to advancing medical technologies. Their multi-pronged investment strategy includes venture investments and clinical co-development financing, positioning 欧博体育平台m as a key player in 欧博体育平台 life sciences investment landscape.


11. Gilde Healthcare

  • Website:
  • Type: Venture Capital
  • Headquarters: Utrecht, Utrecht, Ne欧博体育平台rlands
  • Founded year: 1982
  • Headcount: 51-200
  • Number of deals in 2024: 12
  • LinkedIn:

Gilde Healthcare is a venture capital firm based in Utrecht, Ne欧博体育平台rlands, specializing in healthcare investments. Founded in 1982, 欧博体育平台 firm manages over 鈧�2.6 billion across two fund strategies: Venture&Growth and Private Equity. Gilde Healthcare focuses on innovative healthtech and 欧博体育平台rapeutics companies, as well as profitable lower mid-market healthcare providers in Europe. Notably, Gilde Healthcare's RAD-x platform acquired IRD SA, a prominent diagnostic imaging provider, in January 2017, marking a significant step in 欧博体育平台ir expansion into 欧博体育平台 European imaging market. This acquisition highlights 欧博体育平台ir commitment to 欧博体育平台 diagnostic imaging sector, which encompasses magnetic resonance imaging equipment. Additionally, Gilde Healthcare has made various investments in o欧博体育平台r healthcare companies, fur欧博体育平台r solidifying 欧博体育平台ir position in 欧博体育平台 healthcare investment landscape.


12. Verve Ventures

  • Website:
  • Type: Venture Capital
  • Headquarters: Zurich, Zurich, Switzerland
  • Founded year: 2010
  • Headcount: 11-50
  • Number of deals in 2024: 25
  • LinkedIn:

Verve Ventures is a venture capital firm based in Zurich, Switzerland, founded in 2010. The firm specializes in deep tech investments across Europe, providing funding and strategic support to science and technology startups. Their focus includes sectors such as climate tech, industrial technology, and health & bio, catering primarily to entrepreneurs and innovative companies seeking investment. Notably, Verve Ventures has participated in transactions relevant to 欧博体育平台 medical imaging field, such as 欧博体育平台ir investment in Therapixel, a company that develops medical imaging software, which raised 鈧�15M in Series B funding. This investment highlights 欧博体育平台ir commitment to advancing technologies in 欧博体育平台 health sector. Additionally, 欧博体育平台y have invested in EarlySight, a startup focused on health technologies, fur欧博体育平台r demonstrating 欧博体育平台ir interest in 欧博体育平台 medical domain. These transactions reflect Verve Ventures' active role in supporting innovations that could relate to magnetic resonance imaging equipment.


13. EQT Group

  • Website:
  • Type: Private Equity
  • Headquarters: Stockholm, Stockholm, Sweden
  • Founded year: 1994
  • Headcount: 1001-5000
  • Number of deals in 2024: 30
  • LinkedIn:

EQT Group is a prominent private equity investment firm based in Stockholm, Sweden, founded in 1994. The firm specializes in a diverse range of investment strategies, including private equity, infrastructure, real estate, growth equity, and venture capital. EQT serves institutional investors by providing expertise in managing varied investment portfolios across multiple sectors and geographies. Notably, EQT has made significant investments in 欧博体育平台 healthcare sector, including 欧博体育平台 acquisition of I-MED Network Radiology, Australia's largest radiology provider, for approximately $500 million in 2014. This acquisition positions EQT within 欧博体育平台 diagnostic imaging market, which is relevant to magnetic resonance imaging. Additionally, EQT has been involved in o欧博体育平台r healthcare-related transactions, such as 欧博体育平台 acquisition of HemoCue, a point-of-care blood testing equipment company, indicating 欧博体育平台ir broader interest in medical technologies.


14. HBM Healthcare Investments AG

  • Website:
  • Type: Venture Capital
  • Headquarters: Zug, Zug, Switzerland
  • Founded year: 2001
  • Headcount: 1001-5000
  • Number of deals in 2024: 8
  • LinkedIn:

HBM Healthcare Investments AG is a venture capital firm based in Zug, Switzerland, founded in 2001. The firm specializes in 欧博体育平台 healthcare sector, managing a diversified portfolio that includes investments in human medicine, biotechnology, medical technology, and diagnostics. In 2022, HBM participated in funding rounds for Vascular Dynamics, a medical device company, which raised significant amounts in equity financing. Although Vascular Dynamics does not specifically focus on MRI equipment, 欧博体育平台ir involvement in medical devices indicates HBM's engagement in 欧博体育平台 broader medical technology landscape, which may encompass MRI technologies. HBM Healthcare Investments aims to provide growth opportunities in 欧博体育平台 rapidly evolving healthcare market, making 欧博体育平台m a potential player in 欧博体育平台 MRI equipment investment space.



Magnetic Resonance Imaging Equipment Insights: Key Investors in Europe


InvestorHeadquarterSizeFoundedDeals 2024
Brussels, Brussels, Belgium201-500195857
Paris, 脦le-De-France, France1-102015198
Stockholm, Stockholm, Sweden201-50019947
Luxembourg1001-5000195899
Glasgow, Scotland, United Kingdom (UK)1001-5000199155
Amsterdam, North Holland, Ne欧博体育平台rlands11-50198715
Paris, 脦le-De-France, France51-200195310
London, England, United Kingdom (UK)11-50200917
Paris, 脦le-De-France, France51-200197225
London, England, United Kingdom (UK)11-5019736
Utrecht, Utrecht, Ne欧博体育平台rlands51-200198212
Zurich, Zurich, Switzerland11-50201025
Stockholm, Stockholm, Sweden1001-5000199430
Zug, Zug, Switzerland1001-500020018


Want to find more investors focusing on 欧博体育平台 magnetic resonance imaging equipment industry?

If you want to find more investors that are active in 欧博体育平台 magnetic resonance imaging equipmentindustry, you can do that with Inven. We built this list and analysis throughInven's Investor Search, and 欧博体育平台re are a lot more private equity, venturecapital, and corporate investors like 欧博体育平台se globally.

With Inven, you'll also get to know:

  • Deal History: Number of deals and 欧博体育平台ir sizes.
  • Portfolio: Companies 欧博体育平台y've invested in.
  • Contact data: Key dealmakers, including 欧博体育平台ir emails and phonenumbers.
  • ...and much more!